Novartis: Myocardial Infarction trials
The registry lists 17 Myocardial Infarction studies with Novartis as lead sponsor. 2 are open to participants now and 5 have results posted.
Phase 2 1Phase 3 11Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial InfarctionNot yet recruitingNCT07938411Phase 3
- Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI PatientsRecruitingNCT07142265
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)CompletedNCT01327846Phase 3Results posted
- Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious UveitisTerminatedNCT01090310Phase 3Results posted
- Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)CompletedNCT00414609Phase 3Results posted
- Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary SyndromeCompletedNCT00409578Phase 2Results posted
- A Clinical Trial to Demonstrate the Efficacy of CangrelorTerminatedNCT00305162Phase 3Results posted
- An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)Active, not recruitingNCT07517263Phase 3
- A Study to Evaluate the Impact of Long-term Digital Education vs Standard of Care on LDL-C Levels in Post Myocardial Infarction PatientsCompletedNCT06548555
- Nationwide Trends in Incidence, Healthcare Utilization, and Mortality in Hospitalized Acute Myocardial Infarction Patients in TaiwanCompletedNCT05974397
- In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular DiseaseCompletedNCT05974345
- A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.Active, not recruitingNCT05739383Phase 3
- Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)WithdrawnNCT04637555Phase 3
- Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVDCompletedNCT04023552Phase 3
- Fluvastatin in the Therapy of Acute Coronary SyndromeCompletedNCT00171275Phase 4
- Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCICompletedNCT00093184Phase 3
- Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)CompletedNCT00093158Phase 3